Eulerpool News

Oryzon Genomics Eulerpool News

Oryzon Genomics Ειδήσεις Μετοχών

Το Oryzon Genomics παρακολουθείται από πολλούς δημοσιογράφους και επενδυτές σε όλον τον κόσμο. Τα πιο πρόσφατα νέα Oryzon Genomics τα συγκεντρώνουμε εδώ.

• 3 Σεπτεμβρίου ·

  Yahoo
  ORYZON Continues to Strengthen its Patent Portfolio for Vafidemstat with Additional “Decision to Grant” Communications
• 29 Αυγούστου ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in September
• 31 Ιουλίου ·

  Yahoo
  ORYZON reports financial results and corporate update for half-year ending June 30, 2024
• 8 Ιουλίου ·

  Yahoo
  ORYZON Receives “Decision to grant” for Two Important Patents for Vafidemstat in Japan
• 28 Ιουνίου ·

  Yahoo
  ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders
• 26 Ιουνίου ·

  Yahoo
  ORYZON Announces Presentation of Final Data From PORTICO, Vafidemstat’s Global Phase IIb Trial in Borderline Personality Disorder, at the 37th ECNP Annual Conference
• 14 Ιουνίου ·

  Yahoo
  ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
• 3 Ιουνίου ·

  Yahoo
  ORYZON Announces Journal Publication of Final Phase IIa ALICE Results with Iadademstat in The Lancet Hematology
• 30 Μαΐου ·

  Yahoo
  ORYZON to Provide Corporate Progress Updates at Several Events in June
• 29 Μαΐου ·

  Yahoo
  ORYZON Selected as Associated Partner in the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)